Implications of quality adjusted survival for clinical trials in radiation oncology

British Journal of Radiology

Volumn 79, Issue 940, 2006, Pages 353-355

  Jones, B ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; OUTCOME ASSESSMENT; QUALITY OF LIFE; RADIATION DOSE DISTRIBUTION; RANDOM SAMPLE; TOXICITY; TREATMENT INDICATION;

CHI-SQUARE DISTRIBUTION; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; HUMANS; NEOPLASMS; QUALITY CONTROL; RADIOTHERAPY, HIGH-ENERGY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33645792898     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/15389891     Document Type: Article

References (13)

1. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys, 2000;48:7-16.
2. Nord E. Cost-value analysis in Health care: making sense out of QALY's. Cambridge University Press, 1999.
3. Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999;353:267-72.
4. Jones B, Rosenberg I. Particle therapy Cooperative Oncology Group (PTCOG40), Institute Curie 2004. Br J Radiol 2005;78:99-102.
5. Suit H, Goldberg S, Niemerko A, Trofimov A, Adams J, et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncologica 2003;42:800-8.
6. Errington RD, Ashby D, Gore SM, et al. High energy neutron treatment for pelvic cancers: study stopped because of increased mortality. Br Med J 1991;302:1045-51.
7. Maor MH, Errington RD, Caplan RJ, et al. Fast neutron therapy in advanced head & neck cancer: a collaborative internal randomised trial. Int J Radiat Oncol Biol Phys 1995;32:599-604.
8. Munro AJ. The conventional wisdom and the activities of the middle range. Br J Radiol 2005;78:381-3.
9. Jones B, Dale RG, Carabe A. Conventional wisdom and activities of the middle range. Br J Radiol 2005;78:1119.
10. Bentzen SM. Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother Oncol 1998;46:5-18.
11. Billingham. LJ, Abrams KR. Simultaneous analysis of quality of life and survival data. Stat Methods Med Res 2002;11:25-48.
12. Levy V, Porcher R, Delabarre F, Leporrier M, Cazin B, Chevret S. French Cooperative CLL Group. Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis. J Clin Epidemiol 2001;54:747-54.
13. Davidson SE, Burns MP, Routledge JA, Swindell R, Bentzen SM, West CM. Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SONIA scales and the Franco-Italian glossary. Radiother Oncol 2003;69:195-200.